Biogenic antimicrobials · Founded 2024–2025

Three metal oxides, made by bacteria, stronger together.

GreenOxide develops biogenic metal oxide nanoparticles, copper oxide, zinc oxide and tungsten oxide, as new antimicrobial agents. Combined, they showed above 90% antimicrobial activity against clinical isolates in the lab, including MRSA and Candida albicans.

>90%antimicrobial activity of nanoparticle combinations
75%viable-cell reduction by light-activated WO3
3biogenic metal oxides: CuO, ZnO, WO3
Nanoparticle profile At a glance
CuOActive in the dark, unchanged by light
81.23 nm
ZnOActive in the dark, unchanged by light
89.79 nm
WO3Activated by light
90.18 nm
Why it matters: Antibiotic resistance is a serious problem, and agents that work in combination offer a new line of attack.
The problem

Resistant infections need new agents.

Antibiotic resistance is pushing the search for antimicrobials that work differently.

Resistant bacteria

Methicillin-resistant Staphylococcus aureus (MRSA) is hard to treat with standard antibiotics.

Fungi too

Candida albicans from oral and vaginal samples is part of the same clinical challenge.

Single agents fall short

One agent alone may not reach high kill rates, which is why combinations matter.

Our solution

Biogenic metal oxides that work in synergy.

The nanoparticles are made by a bacterium instead of harsh chemical synthesis, then used alone or combined. Combinations outperformed single nanoparticles in laboratory tests.

Dark-active

CuO and ZnO

Darksignificant activity without light
  • Effective in dark incubation
  • Light did not change their effect
  • Raised lipid peroxidation in microbes
Light-activated

WO3

75%reduction in viable cells for all test organisms
  • Photoactivated by light
  • Effective across bacteria and Candida
  • Highest lipid peroxidation under light
Combination

Synergy

>90%antimicrobial activity of combined nanoparticles
  • Higher activity than single nanoparticles
  • Tested in dark and light
  • Confirmed by live/dead staining
How it works

How it works

From bacterial synthesis to tested combinations.

  1. 1

    Biogenic synthesis

    A bacterium, Stenotrophomonas maltophilia, converts metal salts into oxide nanoparticles.

    biogenicCuOZnOWO3
  2. 2

    Characterisation

    Particles are checked for size, structure and composition.

    XRDFTIRSEMTEM
  3. 3

    Single and combined testing

    Nanoparticles are tested alone and in combinations under dark and light incubation.

    darklight
  4. 4

    Mechanism checks

    Lipid peroxidation and live/dead staining show how the microbes are damaged.

    MDAflow cytometrymicroscopy
Results

Laboratory results

In vitro testing against clinical isolates of E. coli, S. aureus, MRSA and Candida albicans from oral and vaginal samples. No animal or human data yet.

>90%activity of nanoparticle combinations
75%viable-cell reduction, light-activated WO3
82.7%E. coli cells killed by light-activated WO3
78.3%MRSA cells killed by light-activated WO3
Flow cytometry cell death, selected results
TreatmentOrganismReported cell death
WO3, lightE. coli82.7%
WO3, lightS. aureus81.2%
WO3, lightMRSA78.3%
ZnO, dark to lightMRSA45.6% to 73.7%
Combinations, darkTest organismsOver 80%
Combinations, lightTest organismsOver 90%

Source: Francis et al., International Journal of Molecular Sciences 24(12), 9998 (2023). doi:10.3390/ijms24129998

Who it's for

Who it is for

Partners working on infection control.

Antimicrobial developers

  • Synergistic nanoparticle combinations
  • Activity against MRSA
  • Light-activated option

Coating and materials companies

  • Metal oxide antimicrobial agents
  • Dark-active and light-active choices
  • Green synthesis route

Clinical microbiology researchers

  • Tested on clinical isolates
  • Bacteria and Candida covered
  • Mechanism data included
Where we are

What we do not claim

Honest limits at this stage.

Laboratory evidence only

All results are in vitro, against isolates grown in the lab.

Human safety not yet tested

Effects on human cells were not assessed in this study.

Not a medicine

GreenOxide nanoparticles are not approved for any clinical or consumer use.

The team

The team

Founded in 2024–2025 by the research team behind the biogenic metal oxide nanoparticle study.

DF

Dali Vilma Francis

Co-author of the GreenOxide research.

MJ

Manju Nidagodu Jayakumar

Co-author of the GreenOxide research.

HA

Hafiz Ahmad

Co-author of the GreenOxide research.

TG

Trupti Gokhale

Co-author of the GreenOxide research.

Frequently asked questions

What does biogenic mean?

The nanoparticles are made by a living bacterium, Stenotrophomonas maltophilia, rather than by purely chemical synthesis.

Which microbes were tested?

Clinical isolates of E. coli, S. aureus, MRSA and Candida albicans from oral and vaginal samples.

Why combine three nanoparticles?

Combinations showed a synergistic effect, with antimicrobial activity above 90% compared with single nanoparticles.

What does light do?

Light activates WO3, which then reduced viable cells by 75% for all test organisms. CuO and ZnO worked in the dark and light did not change them.

Is it safe for people?

That is not yet known. The study did not test human cells, so safety work is a next step.

The research

Peer-reviewed science behind GreenOxide.

Read the full study behind the product.

Francis, D. V., Jayakumar, M. N., Ahmad, H., & Gokhale, T. (2023). Antimicrobial activity of biogenic metal oxide nanoparticles and their synergistic effect on clinical pathogens. International Journal of Molecular Sciences, 24(12), Article 9998. https://doi.org/10.3390/ijms24129998

https://doi.org/10.3390/ijms24129998